# Deferasirox oral

NDC: 67877-677
Generic name: Deferasirox oral
Labeler / Manufacturer: Ascend Laboratories, LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: GRANULE
Routes: ORAL
Marketing started: 20200716

FDA application: ANDA213374

## Active ingredients

- DEFERASIROX: 360 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"67877-677"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=67877-677
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=2c2842a0-7781-4047-84cd-88bd018e10c7